ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0015671;oxygen transport;5.0;1.0;0.7902410118609202;9.628524252492122;26.519296615914115;7.138016298065211;8.875769919171911E-4;0.6552794972956795;[HBZ, MYC]
GO:0016925;protein sumoylation;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;311.84626772129184;6.250713103064308;0.010437213937211602;0.7159023839588838;[SENP6, UBE2I, BCL11A, SUMO3, NSMCE2, SENP2, PIAS2]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[AHCYL1, RPL3, NUP107, TFRC, ZDHHC6, RPS15, LONP2, ARFIP1, HOMER3, TBC1D22A, SIL1, VPS18, GSTK1, ARRDC1, COG4, COG3, AP1B1, COG1, MYO7A, SYTL3, SCAMP3, BCR, RUFY1, NUP93, UNC50, KIF20A, RPL29, ACOT4, VPS26B, ABCB9, VPS8, VPS11, ATP6V0A2, VPS16, BBS2, XBP1, PMM1, RAB3IP, PMM2, RAB27B, POLA2, NPLOC4, HYOU1, CD24, ARF3, TRAM1, AHCTF1, SRP54, ARHGAP1, CLTA, LYST, TRAM2, XPO5, KIF13B, TMED2, TMED1, RAB8B, TMED4, GRIPAP1, TMED9, SEC13, SSR2, BTN3A2, COMMD1, VAMP8, AFTPH, LSG1, GAL, AGPS, EXOC3, SLU7, VAMP5, PAFAH1B1, EXOC1, RABGAP1, TOMM40, ZDHHC23, HSD17B4, ZDHHC24, DERL2, TRAK1, RGPD1, NAPG, STX11, ARNTL, GGA3, SNX25, LMNA, AP2S1, HEATR3, STX5, CCL19, BID, RAE1, RPL19, PEX16, PEX19, AGK, SYVN1, SNX22, RAB11A, YIF1A, ARCN1, CENPF, SPCS2, SNX19, GPAM, SNX17, SNX14, TAOK2, RAB3GAP2, APBA3, RAB3B, SYS1, DGKD, NCF1, PARK7, IPO4, RAB43, RPH3A, EIF4ENIF1, IPO8, IPO9, LAMP2, RPS9, RPS7, VPS33A, VPS33B, TOMM34, TBC1D2B, RINT1, CHMP4B, SLC27A2, KPNB1, PPID, CARD11, COPB2, COPA, SUCNR1, HSP90B1, NCKIPSD, NLRP3, ECT2, RAB6A, ATP6V1F, AP1M1, TOR1A, VTA1, NUP153, TIMM44, NFKBIA, PAN3, CDK5, TMEM115, BCL3, SFT2D3, YWHAB, GPR89B, AP1G2, AP1G1, NUP62, EVI5L, TNPO1, TNPO2, SNAP29, ARL5A, PDCD6IP, DTX3L, RHBDF2, FGG, TBC1D8, SENP2, ARFGAP1, ACOX2, LCP2, CHMP6, SEC22C, GOSR1, RRBP1, NLRC4, RAB21, AP3M1, RAB20, RAB40C, VPS52, VPS54, RAB28, TIMM8B, ARFGEF2, RPL23A, MCM3AP, VPS41, RAB13, RAB18, RUNDC1, VPS45, SEC24C]
GO:1901741;positive regulation of myoblast fusion;9.0;1.0;0.896240625180289;9.628524252492122;353.2013099653272;6.8867018697843045;0.011821329983997786;0.7484268790654467;[IL4R, FLT3LG, SCGB3A1]
GO:0022008;neurogenesis;4.0;0.8653626801206646;0.6826813400603323;9.292052015870908;21.066225782797595;5.572381008289503;7.050676185779127E-4;0.5349718239061428;[CDK6, RYK, BCL11A, THOC2, BTBD6, TRAK1, DAGLB, CIT]
GO:0042531;positive regulation of tyrosine phosphorylation of STAT protein;11.0;1.0;0.9324289523296623;9.628524252492122;1230.2749798860389;5.618190544320798;0.04117619640118775;0.7197434780388068;[IL6, CD40, ARL2BP, IL23A, CCL5, KIT, IL12A]
GO:0051091;positive regulation of DNA binding transcription factor activity;11.0;0.811012628672052;0.8379352666656883;9.431813958246067;277.8307104044464;4.2636448815154875;0.00929874384583087;0.650471949850128;[MTPN, CRTC2, CD40, ITGB2, CEBPG, CIB1, NLRC4, PARK7, LRP8, AGER, RELA, STK3, MTDH, RPS6KA4, RPS6KA5, EP300, NLRP3, RIPK1, CYTL1, UBE2I, JUP, BUD31, SPHK1, TMEM173, PPRC1, NFKB1, IL6, COPS5, KIT, TRIM14, KRAS, TRIM32, ARHGEF5, CARD11]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[MTPN, CD40, SPHK1, ITGB2, CIB1, NLRC4, AGER, NFKB1, RELA, MTDH, RPS6KA4, RPS6KA5, TRIM14, NLRP3, RIPK1, KRAS, TRIM32, CARD11]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[MAP3K3, XBP1, CD40, JUP, SPHK1, ITGB2, CIB1, BRCA1, THBS1, MTDH, AQP1, C3, PDCL3, RRAS, SP1, TBXA2R, ABL1, CTSH, TEK, EPHA1]
GO:0007016;cytoskeletal anchoring at plasma membrane;6.0;1.0;0.8231203125901445;9.628524252492122;66.89368938276097;7.474488534686424;0.002238871583229107;0.7053660038532718;[JUP]
GO:0002237;response to molecule of bacterial origin;4.0;0.6873818243518346;0.5936909121759173;8.741221057491218;31.746667436368902;4.018171853803189;0.0010625323889495053;0.45548949546759565;[CXCL6, SCARB1, CD40, GFI1, CD80, ABCB4, ATP2A2, PTPN22, COMT, LIAS, RELA, ABR, PABPN1, NLRP7, TBXA2R, CASP3, ABL1, NLRP3, IL12A, HAVCR2, UPF1, XBP1, ABCC2, CCL20, TNFRSF10B, TNFRSF10A, PDCD1LG2, SIRT2, NFKB1, BCR, P2RX7, IL6, TNIP2, CD24]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[BECN1, SUV39H1, ABCB4, ITPR2, RORA, THBS1, AQP3, AGER, TM9SF4, HSP90B1, AQP1, NPEPPS, ALKBH5, CCNB1, MYC, FUNDC1, CASP3, NPPA, LMNA, UBQLN1, EP300, SCAP, ATP7A, CREBBP, EGLN2, ENDOG, ITGA2, CAV1, ARNT, SIRT2, SFRP1, TBL2, DDIT4, HYOU1, TEK, CD24, KCNK3]
GO:0046580;negative regulation of Ras protein signal transduction;9.0;0.8259837884571596;0.8092325194088689;9.394909401310617;288.24654468039586;5.885253329569843;0.009647352445404638;0.6972127541467594;[FLCN, NUP62, SPRY1, MET]
GO:0001942;hair follicle development;4.0;1.0;0.75;9.628524252492122;22.36266381479647;6.166155715036245;7.48458232790436E-4;0.5653374900225189;[NSDHL, HOXC13, LDB2, APCDD1, RELA]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[TCERG1, ZNF175, NAB1, GFI1, GMNN, ARID4A, UBP1, IKZF1, IKZF2, YY1, RPS6KA5, MYC, SAP130, DPF2, TRIM24, WWC3, EP300, SOX8, SOX6, ZNF564, TLE4, ZNF282, ZBTB32, SARS, HCFC2, RUNX2, EID1, ILF3, SFRP1, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, HOXB4, TIMELESS, TRIB3, PPID, MAX, FOXG1, MEPCE, SUPT6H, MTDH, BAG3, TPR, HIVEP1, HESX1, SUDS3, BPTF, TFAP2A, DR1, CREBBP, XRCC6, ZNF263, UBE2I, XRCC5, WFS1, BCL11A, NONO, CAV1, H3F3A, NFKB1, CNOT7, CDK5, QARS, CNOT1, PKIA, SP3, BCL3, CDK2, ZNF658, NFE2L3, ZNF136, EZH2, CDKN1C, USP36, CIITA, BTG2, YWHAB, TCF25, SUV39H1, OTUD7B, BRCA1, LDB2, PTPRK, FLCN, NIPBL, SIN3A, C1QBP, LRRFIP1, HIF1AN, CIC, JARID2, DACT1, ZNF485, TSC22D4, HELLS, KLF11, HBZ, KLF12, PEG3, RFC1, ARID1A, SIRT2, ZFP90, DUSP22, NCOR2, NCOR1, RBL1, TFDP2, NFX1, MTF2, DEPDC1, LCOR, MCPH1, HDAC3, ZNF350, HDAC1, LRP8, RELA, ARNTL, BCLAF1, RXRA, DNAJB5, RBBP7, MTA2, E2F7, ZNF189, E2F8, IRX1, NFYC, PER2, CENPF, GFI1B, HIST3H2A, NFIA, NFIB, NFIC, TAF7, LIMS1]
GO:0048368;lateral mesoderm development;5.0;1.0;0.7902410118609202;9.628524252492122;34.03910770959907;8.390779266560578;0.0011392583018322185;0.7193458537639684;[TEAD2]
GO:0030308;negative regulation of cell growth;6.0;0.6913464685778243;0.6687935468790567;8.673012807464685;80.89021177018715;4.623782033182691;0.0027073225914839173;0.5595807407949613;[SEMA6B, CDKN1A, CDKN2C, EI24, EAF2, ADIPOR2, PPP2CA, FLCN, SERTAD3, SFRP1, GAL, CDK5, SERTAD2, NPPA, SCGB3A1, RBBP7]
GO:0002638;negative regulation of immunoglobulin production;7.0;0.7980440201809971;0.7499413753476991;9.193206181234276;77.13462423321295;7.474488534686424;0.0025816264564307383;0.7331650565203278;[FCRL3]
GO:2000353;positive regulation of endothelial cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;129.82178199018807;6.943860283624253;0.00434501821119318;0.7513499630073597;[CD40, THBS1]
GO:0010811;positive regulation of cell-substrate adhesion;5.0;0.7980440201809971;0.6892630219514189;9.0094850440859;35.30989762708448;5.049685808968129;0.0011817904967337807;0.5484821789659555;[FGA, JUP, PLEKHA2, FGG, ARL2, CIB1, FBLN2, UNC13D, SFRP1, CDK6, ARPC2, C1QBP, ABL1, TEK, EPHA1, LIMS1, S100A10]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[DCTN6, DCTN5, DCTN4, DCTN3, CLTA, KLC1, KIF15, HLA-DMA, HLA-DMB, ACTR1B, KIF3B, AP1G1, AP2S1, CTSE, HLA-DQA1, HLA-DPA1, AP1M1, LAG3, SEC13, FCER1G, AP1B1, KIF23, DYNLL2, CENPE, KIF4A, HLA-DPB1, KIF2C, HLA-DRB3, SEC24C, HLA-DQB1]
GO:0032600;chemokine receptor transport out of membrane raft;11.0;1.0;0.9324289523296623;9.628524252492122;247.9928586842006;9.777073627680469;0.008300097801077391;0.9324289523296623;[CD24]
GO:0042307;positive regulation of protein import into nucleus;9.0;0.9326813400603323;0.8625812952104552;9.592156608321247;778.7460608588023;6.063501560976162;0.02606392983099081;0.706328376990269;[HDAC3, JUP, BAG3, TPR, ECT2, TMEM173]
GO:0071805;potassium ion transmembrane transport;9.0;0.8259837884571596;0.8092325194088689;9.456673995565463;120.6235085317852;4.695669262696007;0.004037160276449102;0.636377369645515;[SLC12A2, KCNG1, KCNK6, KCND1, KCNK12, KCNA3, PKD2L1, ATP1B2, PKD2, AQP1, SLC9A6, KCNN3, KCNK3]
GO:0065003;protein-containing complex assembly;4.0;0.45485133202666184;0.4774256660133309;6.058991556010752;36.471478728154885;2.4440506132939883;0.0012206675708314864;0.3749888620238313;[RPL3, NUP107, CCNH, PKD2L1, IKZF1, GLS, PSMD8, RPS15, PSMD4, TFG, PPAT, MYC, FBXO5, TSPYL1, COG4, BCS1L, PRKAB1, MED6, NUP93, COX7A2L, KCTD10, KCTD14, CD2BP2, TSPYL6, ASF1B, EPB41, XPC, DHX30, SPAST, RNF213, TSPAN4, ATP6V0A2, NCKAP1L, S100A10, VASP, CREBBP, XRCC6, JUP, H3F3A, EIF2AK3, PILRB, RPL3L, SETX, COL1A2, AHCTF1, CD40, GPAA1, SRP54, CLTA, WASL, CLYBL, CHAF1B, CHAF1A, SH3PXD2A, C1QBP, TMED2, HRAS, TEAD2, ATPAF2, HBZ, SEC13, KCND1, FCER1G, ATPIF1, DDB1, GCHFR, ALDH5A1, RAD51C, VAMP4, ALDOA, SLU7, AHNAK, NIP7, KCNA3, HSD17B8, TM9SF4, NAPG, HLA-DMA, RXRA, HLA-DMB, UBN1, AP2S1, STX5, BID, NUBPL, WDR18, GTF2H4, CENPE, BOP1, CENPF, CENPH, CENPJ, CENPK, CENPL, CENPP, DPAGT1, KCNG1, CRTC2, DGKD, NDUFA11, NCF1, NDUFA10, GMNN, TMEM141, IPO4, IGF1R, ZNF207, EP300, OIP5, KNTC1, TLE4, TRAPPC2L, KCTD5, TBC1D20, PRPF3, MRTO4, SNRPG, CHMP4B, FKBP4, PPID, HIST1H2BC, NDUFB10, TUBGCP2, YTHDC1, MAX, COX15, ARL2, KLHL12, ACACA, ATXN2, CCNB1, NLRP3, RIPK1, ECT2, TRAPPC2, TRAPPC3, PRNP, CPSF6, TOR1A, CAV1, NUP153, EIF2S1, VIL1, CNOT7, SYNJ1, ARPC2, MNAT1, YWHAB, USP39, PKD2, PPP6C, NUP62, SNAP29, RBM5, FGA, PDCD6IP, TBP, GPX3, DCXR, FGG, CKAP5, RABGGTA, TAPBP, NDUFS8, NDUFS7, TRAPPC6B, NDUFS6, POLR1E, CHMP6, ITGB3BP, MCM2, COLEC12, STOML2, NDUFB7, HIST1H2BO, HIST1H2BJ, HDAC1, DDX23, ITLN1, NLRC4, FOXRED1, RBBP5, CCL5, RBBP7, POLQ, RRM1, NDUFA7, SEPT11, ANGPT1, RPL23A, P2RX7, MARCKS, RAD51, P2RX4, IMPDH2, POLE3, TAF7, CCDC65, ERCC5, TEK, SEC24C]
GO:0007264;small GTPase mediated signal transduction;6.0;0.7369933605727446;0.6916169928765168;8.741221057491218;26.42836680105094;4.015022244900292;8.845336528452411E-4;0.5284487369119741;[RAB3B, BCAR3, NCKAP1, CDKN1A, RTKN, ROCK2, DOCK8, ARHGAP1, PARK7, RASGRP2, RASGRP4, RAB21, RAB43, RAP1B, ABR, DOCK11, RHOT2, RHOT1, RAB20, RRAS, RAB40C, ARHGDIB, CFL1, RAB28, RAB6A, HRAS, RAB8B, KSR1, SETDB1, RAB27B, RHOC, VAV1, RAB11A, VAV2, NISCH, COL1A2, ALS2, RAB13, CDK2, RAB18, ELMO1, TAX1BP3, KRAS, ARHGEF1, DOCK2, RGL1, KPNB1]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[COLEC12, KCNG1, CRTC2, DGKD, ITLN1, KCNA3, PKD2L1, NLRC4, PKD2, CLYBL, ACACA, GLS, SPAST, RXRA, RNF213, PPAT, RIPK1, ECT2, BID, VASP, POLQ, PRNP, PDCD6IP, KCND1, FCER1G, TOR1A, GPX3, CAV1, DCXR, ATPIF1, EIF2AK3, KCTD5, MARCKS, ALDH5A1, RAD51, P2RX4, KCTD10, IMPDH2, KCTD14, CHMP4B, ALDOA]
GO:0007268;chemical synaptic transmission;7.0;0.7369933605727446;0.7194160455435727;8.663443356448536;23.173347188538074;3.922001705478042;7.755910757418987E-4;0.5514907148670789;[SLC1A4, GLS, ALS2, SYPL1, CDK5, PNOC, VDAC3, MBP, NPTX1, SNCB, APBA3, SPG11, KCNK3, NTSR1, PAFAH1B1]
GO:0007266;Rho protein signal transduction;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;29.60642063139588;5.334422371190153;9.9090025448413E-4;0.6478026081386739;[RHOT2, RHOT1, COL1A2, RTKN, ROCK2, ARHGDIB, CFL1, ARHGAP1, TAX1BP3, ARHGEF1, RHOC]
GO:1903413;cellular response to bile acid;6.0;1.0;0.8231203125901445;9.628524252492122;286.3546574774815;8.67846133901236;0.009584032683311037;0.7669372290569613;[ABCB4]
GO:0000226;microtubule cytoskeleton organization;5.0;0.579397892394798;0.5799399580583193;7.662411396119289;30.307791186580253;3.8212362582156385;0.0010143744957736317;0.4856592118117268;[SPAG16, CIB1, TUBA1C, TUBA1B, TUBB6, KIF19, NUF2, ZNF207, FBXO5, NEFH, TUBG1, CKAP5, IQCG, EML3, NCOR1, ESPL1, KATNAL1, KIF2C, MAPRE3, KIF20A, VAMP4, MAPRE1, KPNB1, PAFAH1B1, MCPH1, HDAC3, TUBGCP2, TUBD1, CCNB1, SPAST, KIF3B, LMNA, CLASP1, MARK2, BBS2, UBE2B, NDC80, RAB11A, NSFL1C, CENPE, CCDC88A, NIN, WEE1, SON, CDK5, FES, KIF4A, CENPJ, TBCE, FGFR1OP, SPRY1, CALM1, SPC25]
GO:1903416;response to glycoside;4.0;0.7866048967936545;0.6433024483968273;8.840066892127851;27.321196622860832;8.16763571524637;9.144158634865458E-4;0.6676932703116032;[ABCB4]
GO:0048010;vascular endothelial growth factor receptor signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.186691500213083;31.002284443533863;5.572381008289503;0.0010376185600805164;0.6599718239061428;[CYFIP2, NCKAP1, NCF1, ROCK2, ITGB3, ELMO1, NCKAP1L, VAV1, VAV2]
GO:0051013;microtubule severing;6.0;1.0;0.8231203125901445;9.628524252492122;33.1981629444775;7.8311634786251565;0.0011111126373447525;0.7236063770733796;[SPAST, KATNAL1]
GO:0002768;immune response-regulating cell surface receptor signaling pathway;6.0;0.6835726970475526;0.6649066611139208;8.807543700422292;76.39633531366081;3.743987405881668;0.0025569165907102184;0.5145880026401528;[CYFIP2, NCKAP1, STOML2, CD40, WIPF2, ARPC1A, PTPN22, WASL, LILRA2, RELA, NCKIPSD, RPS6KA5, ABL1, EP300, CTLA4, NCKAP1L, CSK, HRAS, HLA-DQA1, HLA-DPA1, ACTR2, EIF2B4, CREBBP, FCER1G, BTN2A1, BTN3A2, NFKB1, VAV1, VAV2, CD4, ARPC2, KIT, ELMO1, HLA-DPB1, MNDA, LCP2, KRAS, CALM1, HLA-DRB3, CD24, CARD11, HLA-DQB1]
GO:0001954;positive regulation of cell-matrix adhesion;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;50.25702962731741;5.926926025970411;0.0016820575532361247;0.6262235851885184;[SFRP1, CDK6, JUP, PLEKHA2, ABL1, CIB1, TEK, EPHA1, LIMS1, S100A10]
GO:2000768;positive regulation of nephron tubule epithelial cell differentiation;8.0;1.0;0.875;9.628524252492122;415.05780765516636;8.67846133901236;0.013891611294443005;0.8188169164668168;[CD24]
GO:0048013;ephrin receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;5.395046993006588;0.0010376185600805164;0.6509029541176994;[ACTR2, ARPC2, ROCK2, ARPC1A, AP2S1, WASL, EPHA1, EFNA4, HRAS, EPHB4, VAV2]
GO:0030890;positive regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.1565706318756;6.063501560976162;0.016940604907709607;0.706328376990269;[CDKN1A, CD40, TFRC, FCRL3, NCKAP1L, CARD11]
GO:0033762;response to glucagon;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;74.03337757263446;6.166155715036245;0.0024778305216419678;0.6662568552797195;[ABCC2, ABCB4, CYC1]
GO:0086091;regulation of heart rate by cardiac conduction;8.0;1.0;0.875;9.628524252492122;61.172773623059015;6.193554689224359;0.002047397681241798;0.6917386748366816;[JUP, CAV1]
GO:0001959;regulation of cytokine-mediated signaling pathway;6.0;0.6108066114563391;0.628523618318314;8.112176763124033;55.1119710577094;4.759793790865545;0.0018445480737477274;0.5665363884080561;[IFNAR2, HIST1H2BJ, ANGPT1, SPHK1, GFI1, CAV1, VRK2, IL6, CNOT7, CCL5, MADD, RIPK1, RFFL, CD24, TRIM32, PAFAH1B1]
GO:0034614;cellular response to reactive oxygen species;5.0;0.7671156992804218;0.6737988615011312;9.197741336399668;144.094088465717;5.076593261888053;0.004822699464687224;0.5498582273596049;[BECN1, PCNA, NCF1, PARK7, PTPRK, PKD2, RELA, AQP1, SETX, IL6, PXMP2, CDK2, PPIF, ABL1, ECT2, EZH2]
GO:0043406;positive regulation of MAP kinase activity;12.0;0.7043150770688792;0.8002778511245842;9.369013057007038;2605.6877929993507;4.201124524534153;0.08721002546492271;0.6629660161470909;[CD40, THBS1, AGER, AKAP13, DVL3, RIPK1, CSK, CCL19, HRAS, PDGFRB, MAP3K3, DUSP5, MAP4K2, PDE6H, MAPK8IP3, ERN1, P2RX7, KARS, TAOK2, KIT, MADD, KRAS, CD24, ARHGEF5, EZH2]
GO:0035023;regulation of Rho protein signal transduction;9.0;0.8436909121759173;0.8180860812682478;9.318369324188282;48.758993290020136;4.879233827729558;0.0016319196251719597;0.645764870037956;[PDGFRB, GPR55, VAV1, VAV2, BCR, ABR, FLCN, AKAP13, ALS2, ARHGDIB, ABL1, ARHGEF1, ECT2, MET, ARHGEF5]
GO:0043407;negative regulation of MAP kinase activity;12.0;0.811012628672052;0.8536266269261705;9.539970855150678;2610.1786565788484;5.4730085344763;0.08736033062741366;0.7280102235641875;[PPP2CA, DUSP22, DUSP5, SFRP1, CAV1, GPS1, NUP62, STK38, PAQR3, PTPN22, SPRY1, DUSP14]
GO:1904478;regulation of intestinal absorption;6.0;0.7671156992804218;0.7066781622303554;9.223059144383958;30.838810196503868;7.57984905034425;0.0010321472241496931;0.710754145523778;[ABCB4]
GO:0090037;positive regulation of protein kinase C signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;7.697632086000634;0.007979625599047746;0.7686572628545723;[CD40]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[CDKN1C, BTG2, CDKN1A, CD80, LST1, SIRPG, CIB1, PTPRK, COMT, PKD2, FLCN, ADORA3, RPS6KA2, MYC, CASP3, FNTB, NUP62, TRIM24, CTLA4, IL12A, JARID2, HRAS, EMD, RBM5, HAVCR2, KLF11, KLF13, IGFBP5, SERPINF1, ATPIF1, EMP3, PDCD1LG2, SIRT2, NME1, SFRP1, TWSG1, GAL, TFDP1, KARS, TAX1BP3, B4GALT7, BECN1, THBS1, STK3, TP53INP1, LMNA, CSK, E2F7, TFAP2A, ZBTB17, PRNP, CDKN2C, CAV1, IDH2, GLMN, EAF2, IFT122, PER2, ITCH, IL6, CDK6, CNOT7, FAP, TMEM115, NFIB, CD9, MNDA, SPRY1, CNOT8, TRIM32]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[ANKRD17, MAP3K3, CD40, UBE2I, SLC20A1, ZDHHC13, TNFRSF10B, RHOC, RELA, MTDH, AKAP13, CD4, TFG, TNIP2, UBD, NUP62, ABL1, RIPK1, CCL19, ECT2, TRIM32, CARD11, TMED4]
GO:0045786;negative regulation of cell cycle;5.0;0.5089359064165209;0.5447089650691808;7.0970975870692286;42.34575940812408;3.5270983854209863;0.0014172744586806725;0.47061698731819834;[CDKN1C, TOP2B, BTG2, CDKN1A, ZWILCH, CCNF, GMNN, BUB1B, BRCA1, PTPRK, PKD2, GPR132, RPS6KA2, MYC, CASP3, ZNF207, CASP2, EP300, IL12A, KNTC1, FBXO5, TOPBP1, GTSE1, HRAS, DACT1, TIPIN, PRKAB1, ERN1, TFDP1, RBL1, ESPL1, TFDP2, CTDSP2, TIMELESS, PRR11, MCPH1, PCNA, TP53I13, MAX, XPC, THBS1, PPM1G, CCNB1, FZR1, RAD21, TPR, TP53INP1, TP53BP2, ABL1, RBBP7, E2F7, E2F8, FANCI, ZBTB17, PRNP, CDKN2C, INTS3, DONSON, MAD2L1BP, CNOT10, CDC7, ZWINT, CDK9, CNOT4, CNOT6, CENPF, WEE1, STAG2, RAD51, CDK6, CNOT7, FAP, CDK5, CNOT1, RFWD3, CNOT3, TAOK2, CDK2, INTS7, CNOT8, EIF4G2, EZH2, MAD2L1]
GO:0038095;Fc-epsilon receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.989581884898423;0.002626513627734276;0.6301674496329921;[FCER1G, LCP2, CALM1, NFKB1, VAV1, RELA, CARD11, VAV2]
GO:0097190;apoptotic signaling pathway;5.0;0.6954798709641801;0.6379809473430103;8.529911963824013;23.17027026302992;4.145861845859104;7.75488093814194E-4;0.5022605794604473;[CDKN1A, CD40, DIABLO, CIB1, BRCA1, KRCC1, BBC3, POLB, TFPT, SGPL1, ZMAT1, BAG3, PERP, CASP3, MKNK2, DPF2, ARL6IP5, TP53BP2, ABL1, CASP2, EP300, RIPK1, IL12A, ZNF622, BID, HRAS, XBP1, SIVA1, EYA2, PARP2, CD70, CAV1, G0S2, TNFRSF10B, TNFRSF10A, ERN1, P2RX7, P2RX4, BCL3, DDIT4, TRIB3, CD24]
GO:0060548;negative regulation of cell death;5.0;0.5408746917014966;0.5606783577116685;7.270369308343265;41.94029430001592;2.875336421023895;0.0014037039064071987;0.4372858501489002;[CIB1, PARK7, UBE2Z, IGF1R, AQP1, MYC, CFL1, SOX8, EPHB4, IER3, PDGFRB, CSNK2A1, SERPINF1, FLT3LG, THOC6, NUP93, SFRP1, CFDP1, PPIF, VDAC2, CHMP4B, ADNP, EPHA1, PPID, ABCB4, CORO1A, MTDH, HSP90B1, BCL2L12, HSPH1, BAG3, BAG1, ABL1, NCKAP1L, RIPK1, NTSR1, ATG5, TFAP2A, PRNP, PRELID1, XBP1, UBE2B, WFS1, NONO, RHBDD1, CAV1, PYCR1, TNFRSF10B, TNFRSF10A, NFKB1, SETX, VIL1, NFKBIA, IL6, SON, COPS5, CDK5, QARS, BCL3, HYOU1, MNAT1, CPEB4, AVEN, BTG2, CDKN1A, DOCK8, KIF14, BRCA1, AATF, NNT, SIN3A, CASP3, NUP62, CASP2, CTSH, HRAS, TEAD2, TSC22D4, FGA, DFFA, FCER1G, SPHK2, PARP2, SPHK1, FGG, PLAUR, YWHAZ, DDB1, ITPKB, CREB3, PTRH2, KIT, MET, BECN1, HDAC3, HDAC1, NLRC4, THBS1, RELA, UNG, CLN3, CCL5, LMNA, CCL19, RFFL, SNCB, BID, DCPS, TBX1, ANGPT1, EYA2, RYK, SYVN1, ITCH, GPAM, TNIP2, PSMC1, KRAS, ERCC5, PDCD1, TEK, TRIM32, MAD2L1]
GO:0007595;lactation;6.0;1.0;0.8231203125901445;9.628524252492122;25.956233089099676;5.9928839937622085;8.687317623989867E-4;0.6295966787287501;[OXTR, PPAT, CAV1, ABCB4, CAD, ATP7A, USF2, NME1]
GO:0097193;intrinsic apoptotic signaling pathway;6.0;0.7436939687323844;0.6949672969563367;9.0689084645567;50.98493142520191;4.74012102526684;0.0017064197713422317;0.5655303222604612;[CDKN1A, XBP1, DIABLO, TNFRSF10B, BRCA1, KRCC1, BBC3, ERN1, POLB, ZMAT1, PERP, CASP3, BCL3, DDIT4, ARL6IP5, TP53BP2, ABL1, CASP2, EP300, TRIB3, ZNF622, CD24, HRAS]
GO:0038096;Fc-gamma receptor signaling pathway involved in phagocytosis;10.0;1.0;0.9152410118609203;9.628524252492122;384.64074149301706;4.886724499458715;0.01287357946357817;0.6651483300191682;[CYFIP2, NCKAP1, ACTR2, WIPF2, ARPC1A, WASL, VAV1, VAV2, NCKIPSD, ARPC2, ELMO1, ABL1, NCKAP1L]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[CRTC2, ZNF175, MAML1, CCNH, GFI1, ARID4A, RORA, YEATS4, UBE3A, IKZF1, PARK7, IKZF2, ELK1, YY1, RPS6KA4, RPS6KA5, MYC, DPF2, EP300, SOX8, SOX6, IER5, ZNF564, IER2, FLT3LG, MED6, RUNX2, PIAS2, ARMCX3, IL23A, TBL1XR1, RFX4, HOXB4, PAXIP1, MAX, RLF, SUPT6H, BCL2L12, HSPH1, RAD21, HLTF, SCAP, NLRP3, HOXC4, RIPK1, CYTL1, TFAP2A, ZBTB17, ZNF143, DR1, CREBBP, XBP1, XRCC6, JUP, PBX3, EAF2, ERLIN2, FLI1, NFKB1, SETX, CDK9, NFKBIA, IL6, STAG1, TFCP2, COPS5, CNOT7, SP1, SP3, MAFF, BCL3, MNAT1, NFE2L1, CIITA, CD40, SETD3, ONECUT2, ELL, DDX41, HOXC13, BRCA1, LDB2, AATF, PKD2, FLCN, NIPBL, SIN3A, HRAS, TEAD2, ZNF485, KLF13, RBM15, PEG3, NCOA6, MKL1, ARNT, SENP2, SAFB, TMEM173, PPRC1, SIRT2, GNL3, CREB3, GAL, TFDP1, RBL1, TFDP2, ELF4, IRF4, MTF2, TFEC, MET, HDAC3, ZNF350, HDAC1, WBP2, CEBPG, RELA, ARNTL, RXRA, MTA2, E2F7, E2F8, TBX1, ZNF462, NFYC, ATAD2, ARID3B, GRHL1, USF2, NFIA, NFIB, TNIP2, TTC5, NFIC, PSMC1, TAF7, CAMK1, MIXL1]
GO:0001890;placenta development;4.0;1.0;0.75;9.628524252492122;49.86610466882393;6.193554689224359;0.0016689736466849693;0.5667386748366816;[ABCB4, CCNF, E2F7, E2F8]
GO:0060940;epithelial to mesenchymal transition involved in cardiac fibroblast development;7.0;1.0;0.8509193652572005;9.628524252492122;26.141399598032546;9.083926447120524;8.749291188139309E-4;0.8154717862087246;[SPRY1]
GO:0042832;defense response to protozoan;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;69.6526388451159;6.832634648514029;0.0023312111388408135;0.6725415662651573;[CD40, IL4R, IRF4, CLEC7A, BCL3, IL12A, LYST, HRAS]
GO:0043249;erythrocyte maturation;4.0;0.8933024483968273;0.6966512241984136;9.377209824211215;39.55885145263534;7.138016298065211;0.0013239991574647877;0.6150384854347593;[HBZ]
GO:0002455;humoral immune response mediated by circulating immunoglobulin;7.0;1.0;0.8509193652572005;9.628524252492122;48.293467131004675;8.390779266560578;0.001616338883576055;0.7800242071602487;[EXO1, BCL3, HLA-DQB1]
GO:0043491;protein kinase B signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;6.250713103064308;8.845336528452411E-4;0.6427820713687392;[SETX, CD40, CCL5, SIRT2]
GO:0071392;cellular response to estradiol stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;338.1710882258028;6.221725566191056;0.011318281988697268;0.6412996473849828;[SFRP1, ITGA2, ABCB4]
GO:0051387;negative regulation of neurotrophin TRK receptor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;297.5747140953686;8.390779266560578;0.00995955788091634;0.7800242071602487;[SPRY1]
GO:0097068;response to thyroxine;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;148.64568421023415;8.16763571524637;0.004975037278085989;0.7408135829017477;[ABCB4, CRLS1]
GO:0051023;regulation of immunoglobulin secretion;8.0;0.8933024483968273;0.8216512241984136;9.523163736834295;116.24681071054106;6.943860283624253;0.0038906761391443723;0.7301093378270707;[GPI, IL6, XBP1, CD40]
GO:0000281;mitotic cytokinesis;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;28.615093046006976;5.649939242635378;9.577214123380678E-4;0.5791791674783379;[SEPT11, PDCD6IP, RTKN, KIF23, RHOC, CIT, SPAST, SON, ESPL1, KIF4A, CFL1, JTB, CHMP4B, KIF20A, ECT2]
GO:0050859;negative regulation of B cell receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;309.61561130321576;7.9853141584524145;0.010362555874359037;0.7833693374183408;[FCRL3]
GO:0032782;bile acid secretion;9.0;1.0;0.896240625180289;9.628524252492122;69.42950734212523;8.16763571524637;0.002323743128241031;0.8139338954918922;[ABCB4, STARD10]
GO:0071312;cellular response to alkaloid;6.0;0.7866048967936545;0.7164227609869718;9.245532000236016;164.36700762083373;6.280566066213989;0.005501215824366272;0.6443087532925187;[RAD51, CASP3, ABCB4]
GO:0050852;T cell receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;219.43154282413207;4.981283082083729;0.007344176262756358;0.6699840603320352;[EIF2B4, STOML2, BTN2A1, PTPN22, BTN3A2, NFKB1, RELA, CD4, HLA-DPB1, LCP2, CSK, HLA-DRB3, HRAS, HLA-DQA1, CARD11, HLA-DPA1, HLA-DQB1]
GO:0034163;regulation of toll-like receptor 9 signaling pathway;8.0;0.8653626801206646;0.8076813400603323;9.4949928598676;90.3094294018114;7.8311634786251565;0.0030225753288688696;0.7754860644832351;[FCRL3]
GO:0033590;response to cobalamin;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;87.04156493882871;8.390779266560578;0.002913202846179917;0.7800242071602487;[CD40, RELA]
GO:0043537;negative regulation of blood vessel endothelial cell migration;10.0;0.9326813400603323;0.8815816818910864;9.584072489921288;356.3539069568923;6.311337724880743;0.01192684456815238;0.7380031166185408;[STARD13, JUP, TBXA2R, THBS1]
GO:0031295;T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;354.8971974647038;5.845247994956144;0.011878089812402261;0.6951668794741764;[CD80, CAV1, CTLA4, CSK, PDCD1, PDCD1LG2, CCL19, CD24, VAV1, CARD11]
GO:1901652;response to peptide;5.0;0.622025257344104;0.6012536405329723;8.140447197062288;43.799236587536825;3.924871147905995;0.0014659210318310812;0.4909591048900068;[ERRFI1, BTG2, OXTR, CD40, MAX, ABCB4, PTPN22, AGER, CRHR1, RELA, IGF1R, RAP1B, PPAT, NPPA, SCAP, CSK, CYC1, RAB8B, EIF2B4, PRNP, KLF11, XBP1, ABCC2, IGFBP5, CAV1, CAD, TSHR, NFKB1, NFKBIA, GAL, CDK5, SP1, MARS, RAB13, TIMELESS, TRIB3, TEK]
GO:0048304;positive regulation of isotype switching to IgG isotypes;11.0;1.0;0.9324289523296623;9.628524252492122;1407.9016349495496;7.57984905034425;0.04712120069255247;0.8200627852632958;[CD40, PAXIP1]
GO:0043410;positive regulation of MAPK cascade;10.0;0.6634067003016617;0.7469443620117512;9.174268980214526;1017.2390743488962;3.4929394666096676;0.03404607636272706;0.5938700986216354;[CD40, NCF1, CIB1, PTPN22, IGF1R, AKAP13, ARL6IP5, HRAS, EPHB4, HAVCR2, PDGFRB, FGA, DUSP5, MAP4K2, KSR1, FCRL3, FGG, MAPK8IP3, ERN1, DUSP22, KARS, KIT, MADD, EPHA1, MET, ARHGEF5, THBS1, AGER, STK3, RAP1B, CCL5, ABL1, DVL3, RIPK1, CSK, ZNF622, CCL19, TBX1, MAP3K3, PDE6H, ANGPT1, CCL20, RYK, GPR55, P2RX7, CD4, IL6, TAOK2, KRAS, TEK, CD24, EZH2]
GO:0043536;positive regulation of blood vessel endothelial cell migration;10.0;0.9326813400603323;0.8815816818910864;9.584072489921288;355.43002650478036;5.8067817141283475;0.011895923120858621;0.7122000987644093;[MAP3K3, CD40, P2RX4, ANGPT1, SP1, ABL1, CIB1, THBS1]
GO:0050982;detection of mechanical stimulus;4.0;0.7369933605727446;0.6184966802863723;8.712233520617966;57.71052606361059;5.9928839937622085;0.0019315193712475664;0.5564763661386056;[JUP, ITGA2, KIT, PKD2L1, PKD2]
GO:0071260;cellular response to mechanical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;56.1235610070294;5.420364800990877;0.00187840507897962;0.5674387198563348;[MTPN, CD40, BAG3, ITGA2, NPPA, CASP2, TNFRSF10B, TNFRSF10A, NFKB1, AQP1]
GO:0071300;cellular response to retinoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;200.602279209425;5.54296712308321;0.006713977754809188;0.606587909038952;[SETX, TBX1, SERPINF1, ZNF35, TEAD2, AQP1]
GO:0001657;ureteric bud development;8.0;1.0;0.875;9.628524252492122;36.921511297847346;6.139487467954083;0.0012357297559360753;0.6889736746265369;[SFRP1, SDC1, SPRY1]
GO:0072112;glomerular visceral epithelial cell differentiation;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;72.77032193269073;7.8311634786251565;0.002435557186049328;0.7514054297404357;[CD24]
GO:0006309;apoptotic DNA fragmentation;9.0;1.0;0.896240625180289;9.628524252492122;682.1166149099336;7.004484905440688;0.022829829235937554;0.7544503089863854;[FEN1, DFFA, ENDOG, CASP3, DNASE1L3, KPNB1]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[CXCL6, SCARB1, CD40, GFI1, CD80, ABCB4, ATP2A2, PTPN22, COMT, LIAS, RELA, ABR, PABPN1, NLRP7, TBXA2R, CASP3, ABL1, NLRP3, IL12A, HAVCR2, UPF1, XBP1, ABCC2, CCL20, TNFRSF10B, TNFRSF10A, PDCD1LG2, NFKB1, BCR, P2RX7, IL6, TNIP2]
GO:0032376;positive regulation of cholesterol transport;8.0;0.811012628672052;0.780506314336026;9.32314260294094;149.26567110214077;6.7325511899570465;0.004995787681406127;0.719302980950052;[NFKBIA, ABCB4, ABCA12]
GO:0033189;response to vitamin A;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;42.3983228833862;6.781341354126479;0.0014190337108936392;0.6977174774718518;[ABCB4]
GO:0071549;cellular response to dexamethasone stimulus;9.0;1.0;0.896240625180289;9.628524252492122;704.2721689024621;6.343086423195323;0.023571355689363423;0.7206263598461826;[ERRFI1, ABCC2, SERPINF1, ABCB4, DDIT4, AQP1]
GO:0086073;bundle of His cell-Purkinje myocyte adhesion involved in cell communication;6.0;1.0;0.8231203125901445;9.628524252492122;24.262698198658363;7.9853141584524145;8.120506736983656E-4;0.7314896500084853;[JUP]
GO:0043549;regulation of kinase activity;8.0;0.5318528234273745;0.6409264117136872;7.75672207559053;45.50531354295741;2.9903566770753884;0.0015230218921594328;0.5279269795314422;[ERRFI1, NCF1, CCNH, CCNF, CIB1, PARK7, IGF1R, NEK1, EPHB4, PDGFRB, PAQR3, MAPK8IP3, CDC25A, ERN1, SFRP1, KARS, CCNE2, IL23A, CCNE1, MADD, JTB, MTCP1, TRIB3, ADNP, EPHA1, PKMYT1, AGER, STK3, CCNB1, HSPH1, STK38, ABL1, DVL3, NCKAP1L, RIPK1, ECT2, MARK2, PRNP, XRCC6, XRCC5, CAV1, TNFRSF10B, TNFRSF10A, PILRB, CCDC88A, CDK6, CDK5, QARS, GNAQ, PKIA, FGFR1OP, CALM3, CRIPAK, CALM1, MNAT1, CD24, CALM2, CCNJL, EZH2, CDKN1C, CDKN1A, CD40, ITGB3, KIF14, PTPN22, LDB2, PKD2, DUSP14, CKS1B, AKAP13, CASP3, NUP62, HRAS, DUSP5, MAP4K2, KSR1, ZFP91, OXSR1, VAV2, DUSP22, RBL1, ALS2, KIT, LCP2, MAPRE3, CHMP6, MET, ARHGEF5, MCPH1, VAC14, GPS1, LRP8, THBS1, PPP2CA, CCL5, CSK, ZNF622, CCL19, MAP3K3, CDKN2C, PDE6H, ANGPT1, RYK, P2RX7, CENPE, CD4, PIK3IP1, TAOK2, TAF7, KRAS, SPRY1, CAMK1, TEK]
GO:0034394;protein localization to cell surface;5.0;1.0;0.7902410118609202;9.628524252492122;29.829169826127035;6.686031174322154;9.983554695705216E-4;0.6321649570480018;[PIGU, ANGPT1, PTPRK, FBLN5]
GO:0040037;negative regulation of fibroblast growth factor receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.517298617381897;298.26786127592857;7.004484905440688;0.00998275689325772;0.7091290490632969;[SPRY1, THBS1]
GO:1904498;protein localization to mitotic actomyosin contractile ring;9.0;1.0;0.896240625180289;9.628524252492122;102.47693557236114;8.67846133901236;0.003429810810352553;0.8400575416471059;[RTKN]
GO:0061098;positive regulation of protein tyrosine kinase activity;11.0;0.8436909121759173;0.8542744084176208;9.55953138100517;2154.6219316186807;5.8650506222523235;0.07211325701743153;0.7323679139043926;[PRNP, HSPH1, NCF1, CCL5, CD24, LRP8]
GO:0007179;transforming growth factor beta receptor signaling pathway;8.0;0.7586651285174919;0.754332564258746;9.05316010758856;29.903672154863813;5.2552850506314295;0.0010008489954655988;0.6437555218850388;[DUSP22, TWSG1, FUT8, COL1A2, PTPRK]
GO:0060449;bud elongation involved in lung branching;6.0;1.0;0.8231203125901445;9.628524252492122;21.218694376440094;7.8311634786251565;7.101706051943016E-4;0.7236063770733796;[SPRY1]
GO:0002283;neutrophil activation involved in immune response;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;82.20461051260416;3.594988720963838;0.002751314334510546;0.5347672556313635;[SERPINA3, PYGB, GPI, SIGLEC9, FRMPD3, ITGB2, HK3, PSMD7, ACTR1B, PSMD2, LAMP2, CTSH, GUSB, SNAP29, ACTR2, SERPINB1, FCER1G, PLAUR, COMMD3, RNASE3, TMEM173, UNC13D, SERPINB6, VAMP8, ACLY, ALDOC, DOCK2, ALDOA, SLC27A2, DNASE1L3, KPNB1, CSTB, PDXK, CLEC12A, UBR4, IQGAP2, LILRA2, C3, RAP1B, COMMD9, PSMB1, NCKAP1L, RAB6A, AP1M1, XRCC6, TMEM30A, JUP, XRCC5, HSPA6, SURF4, LILRB3, NFKB1, FABP5, IMPDH2, RAB18, PTX3, MNDA, DEGS1, MAN2B1]
GO:0051291;protein heterooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;5.113634533568402;0.00140677858073304;0.5846318204451575;[HBZ, RRM1, SEPT11, XRCC6, CPSF6, JUP, YWHAB, IKZF1, HSD17B8, PRKAB1, GCHFR, COL1A2, NUP62, RIPK1, HRAS, S100A10]
GO:0042059;negative regulation of epidermal growth factor receptor signaling pathway;8.0;0.8436909121759173;0.7968454560879586;9.417215158824915;234.05310184950287;6.113511981550823;0.00783354668478672;0.6876452870438905;[ERRFI1, NUP62, SPRY1, CHMP6]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[ERRFI1, CD40, DOCK8, ARHGAP1, DOCK11, RGS1, ARHGDIB, EVI5L, TBC1D22A, HRAS, SEC13, TBC1D8, TBC1D2B, VAV1, ARFGAP1, BCR, DEPDC1B, SFRP1, ALS2, TBC1D20, DEPDC1, PKP4, TAX1BP3, ARHGEF1, DOCK2, EPHA1, ARHGEF5, RABGAP1, RASGRP2, RIC8A, ABR, ARHGAP21, CCL5, DVL3, NCKAP1L, CCL19, ECT2, A2M, S100A10, STARD13, CCL20, RCC2, ARHGAP25, GNAQ, RUNDC1, RAB3GAP2, SMAP1, RAB3GAP1, EZH2, LIMS1]
GO:0006367;transcription initiation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;4.629579150867016;0.015969835568764485;0.6329975182530758;[CREBBP, CDKN1A, TBP, MAML1, CCNH, RORA, ZNF45, GTF2H4, MED6, RUNX2, GTF2E2, CDK9, RXRA, POLR2B, NPPA, MED20, TAF7, POLR2G, TAF5, MNAT1, TEAD2, GTF2I]
GO:0002159;desmosome assembly;6.0;1.0;0.8231203125901445;9.628524252492122;75.07953051527643;8.390779266560578;0.0025128443191556717;0.7522251544931926;[JUP]
GO:0006636;unsaturated fatty acid biosynthetic process;9.0;0.7508913569872202;0.7716863036738992;9.34084218004034;458.36729553176707;6.343086423195323;0.01534114087766428;0.7206263598461826;[FADS3, ELOVL5, DEGS1, FADS1]
GO:0043031;negative regulation of macrophage activation;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;126.92306413003195;7.57984905034425;0.00424800073309046;0.738553198190834;[CD200]
GO:0045332;phospholipid translocation;8.0;1.0;0.875;9.628524252492122;116.86638763413639;6.641579411751319;0.003911412821194078;0.7146506799819907;[P2RX7, TMEM30A, ABCB4]
GO:1990963;establishment of blood-retinal barrier;4.0;1.0;0.75;9.628524252492122;32.15320660831846;9.777073627680469;0.001076138889173156;0.75;[ABCB4]
GO:0044089;positive regulation of cellular component biogenesis;4.0;0.5265193887476639;0.5132596943738319;6.612989351641951;23.240714864746945;3.5564834575807303;7.778458112376373E-4;0.431878729414073;[HRK, NCKAP1, OXTR, WIPF2, ARPC1A, WASL, LDB2, FNBP1L, WDR43, DOCK11, NUP62, ATP7A, HRAS, ACTR2, PDCD6IP, SWAP70, RHOC, DDB1, SFRP1, KIT, ADNP, LCP1, EPHA1, MAPRE1, MET, ARHGEF5, BECN1, PAXIP1, HEATR1, ARL2, IQGAP2, BCLAF1, TPR, ABL1, NCKAP1L, CCL19, BID, CLASP1, S100A10, VASP, CAV1, GTF2H4, SETX, VIL1, P2RX7, CCDC88A, CNOT6, PAN3, ARPC2, CNOT1, FES, PSMC1, CENPJ, SDC1, RAB3GAP2, ERCC5, FAM98A, TEK, RAB3GAP1, LIMS1]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[BECN1, ZNF175, CD40, DDX41, ZC3HAV1, LYST, RELA, NLRP3, IFNAR2, APOBEC3F, DTX3L, APOBEC3H, TMEM173, UNC13D, ITCH, ILF3, IL6, CNOT7, GPAM, POLR3B, POLR3C, IL23A, POLR3E, DDIT4, SERINC3, APOBEC3A, EXOC1]
GO:0016055;Wnt signaling pathway;7.0;0.5916390046238794;0.6467388675691402;7.647522783625538;28.581916314885376;4.0633408221711;9.566110170045473E-4;0.558718803867703;[USP34, KLHL12, APCDD1, GNG2, GNAT2, MYC, AP2S1, DVL3, MARK2, DACT1, TLE4, CSNK2A1, UBE2B, RYK, SENP2, DDB1, SFRP1, CCNE1, SDC1, TAX1BP3, CALM1, CD24, MET, CSNK1G2, TNRC6A, CSNK1G1]
GO:0048041;focal adhesion assembly;8.0;1.0;0.875;9.628524252492122;92.53238439646684;6.599019797332524;0.0030969756320103773;0.712474179321389;[ITGA2, RCC2, TAOK2, PTPRK]
GO:1905184;positive regulation of protein serine/threonine phosphatase activity;11.0;1.0;0.9324289523296623;9.628524252492122;1090.3691173458615;9.777073627680469;0.036493673089069714;0.9324289523296623;[FCRL3]
GO:0071217;cellular response to external biotic stimulus;4.0;1.0;0.75;9.628524252492122;54.03966511499906;9.777073627680469;0.001808658958857907;0.75;[ABCB4]
GO:1905233;response to codeine;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;91.95678064542024;9.777073627680469;0.0030777106924725914;0.8509193652572005;[ABCB4]
GO:1905232;cellular response to L-glutamate;7.0;1.0;0.8509193652572005;9.628524252492122;543.0623632319648;8.390779266560578;0.01817580857297763;0.7800242071602487;[ABCB4]
GO:0034260;negative regulation of GTPase activity;6.0;1.0;0.8231203125901445;9.628524252492122;61.14468506277762;5.970411137910149;0.0020464575824072424;0.6284474158353811;[RTKN, RCC2, GPS1, PDE6D, TMED2, ARL2, SPRY1, IQGAP2, HRAS]
GO:1905231;cellular response to borneol;6.0;1.0;0.8231203125901445;9.628524252492122;82.1226699471212;9.777073627680469;0.0027485718575255523;0.8231203125901445;[ABCB4]
GO:1905237;response to cyclosporin A;6.0;0.9326813400603323;0.7894609826203107;9.533214072687796;72.72722829191152;9.777073627680469;0.002434114880674206;0.8231203125901445;[ABCB4]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[CXCL6, OXTR, AHCYL1, DGKD, DGKA, DEFB1, HEBP1, AKAP13, GPR132, GNAT2, RGS1, ADORA3, NPPA, OR56B1, HOMER3, CCR2, PDGFRB, SPHK2, SPHK1, RHOC, VAV1, VAV2, SFRP1, GAL, SPNS1, ARHGEF1, DAGLB, GPRC5D, ARHGEF5, SUCNR1, ROCK2, IQGAP2, CRHR1, RIC8A, C3, ABR, GNG2, TBXA2R, CCL5, CCL19, ECT2, NTSR1, CCR10, SLC12A2, CCL20, CAV1, GPR55, TSHR, BAIAP3, GPR180, GNAQ, GNB2, PNOC, NMUR1, CALM3, CALM1, CALM2]
GO:1905235;response to quercetin;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;83.8240692754011;9.777073627680469;0.0028055161618830964;0.7902410118609202;[ABCB4]
GO:0090263;positive regulation of canonical Wnt signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;236.52854047757646;5.244474134527214;0.007916397387918217;0.6432026511327102;[SFRP1, JUP, TBL1XR1, CAV1, USP34, NFKB1, ARNTL, DACT1]
GO:0045577;regulation of B cell differentiation;8.0;0.7369933605727446;0.7434966802863723;9.223059144383958;130.3775146173893;6.518977089658987;0.004363618082098712;0.7083807915285978;[SFRP1, XBP1, FCRL3, NCKAP1L, CARD11]
GO:0043552;positive regulation of phosphatidylinositol 3-kinase activity;11.0;0.9326813400603323;0.8987696223598284;9.597752593825367;732.6859750532908;6.375876246018314;0.024522340210466318;0.7584915600596062;[PDGFRB, KIT, CCL19, TEK, VAV2]
GO:0042100;B cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.387362195675234;50.60132884827668;6.166155715036245;0.00169358093831245;0.6384578026126634;[CD40, ABL1, CARD11]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[SERPINA3, PYGB, GPI, SIGLEC9, FRMPD3, ITGB2, HK3, PSMD7, ACTR1B, PSMD2, LAMP2, CTSH, GUSB, SNAP29, ACTR2, SERPINB1, FCER1G, PLAUR, COMMD3, RNASE3, TMEM173, UNC13D, SERPINB6, VAMP8, ACLY, ALDOC, DOCK2, ALDOA, SLC27A2, KPNB1, CSTB, PDXK, CLEC12A, UBR4, IQGAP2, C3, RAP1B, COMMD9, PSMB1, NCKAP1L, RAB6A, AP1M1, XRCC6, TMEM30A, JUP, XRCC5, HSPA6, SURF4, LILRB3, NFKB1, FABP5, IMPDH2, RAB18, PTX3, MNDA, DEGS1, MAN2B1]
GO:0043278;response to morphine;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;93.3430750065417;6.280566066213989;0.0031241087171554015;0.6721078059595746;[ABCB4, RELA]
GO:0003143;embryonic heart tube morphogenesis;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;47.28828305781204;5.618190544320798;0.0015826962772532312;0.610434838299289;[TMED2, PKD2, TEAD2]
GO:1901557;response to fenofibrate;5.0;1.0;0.7902410118609202;9.628524252492122;104.6800071720804;9.777073627680469;0.00350354563415944;0.7902410118609202;[ABCB4]
GO:0042104;positive regulation of activated T cell proliferation;10.0;1.0;0.9152410118609203;9.628524252492122;649.8896198547563;6.599019797332524;0.021751220713853325;0.7527151911823093;[GPAM, IL23A, IL12RB1, CD24, AGER]
GO:0042744;hydrogen peroxide catabolic process;6.0;0.9326813400603323;0.7894609826203107;9.55953138100517;235.80375524332874;6.481236761676141;0.007892139478392308;0.6545710619905948;[HBZ, GPX3, PRDX1]
GO:0032913;negative regulation of transforming growth factor beta3 production;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;85.63944001314535;9.777073627680469;0.002866274986747803;0.8509193652572005;[CD24]
GO:0071681;cellular response to indole-3-methanol;6.0;1.0;0.8231203125901445;9.628524252492122;467.4090985487011;8.16763571524637;0.01564376188754665;0.7408135829017477;[JUP, BRCA1]
GO:0033209;tumor necrosis factor-mediated signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;30.19135422731818;5.395046993006588;0.00101047745553359;0.6268223193749;[NFKBIA, CD40, KARS, CD70, TNFRSF10B, RIPK1, TNFRSF10A, RELA, LIMS1]
GO:0009914;hormone transport;4.0;0.5756379274792419;0.5378189637396209;7.480089839325334;21.707737847050485;5.358233019883872;7.265384500450821E-4;0.524020285820179;[IL6, GAL, ABCC2, SNX19, ABCB4, PARK7, CRHR1]
GO:0007218;neuropeptide signaling pathway;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;26.976932752798508;5.123113277522946;9.028936615729279E-4;0.5851165638517994;[GAL, NPPA, PNOC, NMUR1, NTSR1]
GO:0061092;positive regulation of phospholipid translocation;9.0;1.0;0.896240625180289;9.628524252492122;348.31453857334856;8.67846133901236;0.011657774143316984;0.8400575416471059;[ABCB4]
GO:0001759;organ induction;7.0;0.8436909121759173;0.7727648213451592;9.377209824211215;112.34202169575063;7.212124270218933;0.0037599863649012966;0.7197477358342742;[SPRY1]
GO:0032597;B cell receptor transport into membrane raft;11.0;0.9326813400603323;0.8987696223598284;9.59462270081644;336.41565742558566;9.777073627680469;0.011259529299599152;0.9324289523296623;[CD24]
GO:0072139;glomerular parietal epithelial cell differentiation;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;51.0109489693332;9.083926447120524;0.0017072905551300363;0.8154717862087246;[CD24]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[ERRFI1, CXCL6, GPI, COPA, NCF1, EBI3, IL27, PARK7, AGER, CCL5, NPPA, IL12A, FAM3C, CCL19, CMTM7, UBE2I, CCL20, CD70, BUD31, FLT3LG, NETO2, IL6, GAL, CDK5, IL23A, PNOC, SCGB3A1, CHMP6, KCNK3, HBEGF]
GO:0010623;programmed cell death involved in cell development;4.0;0.7866048967936545;0.6433024483968273;8.85533436425864;27.76572612296292;7.57984905034425;9.292938658043862E-4;0.6376338329336335;[KIT, CASP2, DNASE1L3]
GO:0030334;regulation of cell migration;6.0;0.4770562410916853;0.5616484331359872;7.1128459440373675;36.74126027361157;3.1319826581748256;0.0012296969163702938;0.48329005138129355;[CXCL6, SCARB1, GPI, CD40, MCTP1, ONECUT2, DOCK8, ITGB3, KIF14, CIB1, WASL, LDB2, PTPRK, IGF1R, FLCN, NIPBL, ADORA3, C1QBP, ARHGDIB, CTSH, IL12A, ATP7A, GTSE1, HRAS, CCR2, SEMA6B, PDGFRB, TBCCD1, IGFBP5, ITGA2, SPHK1, SWAP70, SERPINF1, RHOC, PTP4A1, BCR, NISCH, CREB3, SFRP1, KARS, IL23A, RUFY3, KIT, EPHA1, MAPRE1, MET, HBEGF, CD151, ROCK2, CD99L2, THBS1, CORO1A, ABR, RRAS, TBXA2R, CCL5, TP53INP1, LMNA, ABL1, NCKAP1L, LRIG2, CCL19, RFFL, MTA2, CLASP1, RNF20, MAP3K3, STARD13, XBP1, ANGPT1, JUP, CCL20, RCC2, IDH2, RAB11A, VIL1, IL6, P2RX4, CDK5, SP1, FGFR1OP, TEK, TRIM32]
GO:0030336;negative regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.20713857156096;158.04059951544355;4.3090134865453384;0.00528947663847651;0.5712825153487487;[RNF20, STARD13, MCTP1, IGFBP5, JUP, SERPINF1, IDH2, WASL, PTPRK, THBS1, BCR, NISCH, ABR, FLCN, SFRP1, RRAS, TBXA2R, ADORA3, TP53INP1, ARHGDIB, EPHA1, CLASP1]
GO:0072659;protein localization to plasma membrane;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;65.42666064804821;4.677207199856271;0.002189771451718415;0.5623129063031725;[BBS2, RAB3B, GRIPAP1, SYS1, FCER1G, JUP, ROCK2, ZDHHC23, ABCA12, RAB11A, GAK, RAB40C, SLMAP, RAB13, TMED2, VAMP5, RAB8B, S100A10]
GO:0070948;regulation of neutrophil mediated cytotoxicity;7.0;0.7192862368539868;0.710562483684194;9.117698628726131;29.221148044769922;8.390779266560578;9.78005527732576E-4;0.7800242071602487;[DNASE1L3]
GO:0033280;response to vitamin D;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;74.55580141320215;6.375876246018314;0.002495315577434836;0.6769819729871445;[CD4, SFRP1, ABCB4, AQP3]
GO:0000915;actomyosin contractile ring assembly;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;135.1741411845403;7.9853141584524145;0.004524156856617609;0.7833693374183408;[PDCD6IP, RTKN, KIF23]
GO:0008361;regulation of cell size;5.0;0.7763722522362496;0.6784271379790451;8.999915593069748;28.02071028012121;5.54296712308321;9.378279560736312E-4;0.5737086083097278;[SLC12A2, P2RX7, MTPN, ATP7A, CLCN3, VAV1, AQP1, VAV2]
GO:1902259;regulation of delayed rectifier potassium channel activity;10.0;0.8933024483968273;0.861892236059334;9.52844079393514;241.32610565142676;7.069023426578259;0.008076967576758647;0.7767511986393403;[KCNG1, NPPA]
GO:0048339;paraxial mesoderm development;5.0;1.0;0.7902410118609202;9.628524252492122;34.03910770959907;7.697632086000634;0.0011392583018322185;0.6838982747154925;[TEAD2]
GO:0001570;vasculogenesis;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;21.066225782797595;5.6339389012889365;7.050676185779127E-4;0.5381198974168686;[SGPL1, PAXIP1, CAV1, GLMN, CCM2, RASIP1, TEAD2]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[TCERG1, ZNF175, GFI1, IKZF2, YY1, MYC, SAP130, WWC3, EP300, SOX8, SOX6, ZNF564, TLE4, ZBTB32, SARS, HCFC2, EID1, BRMS1, TBL1XR1, CCNE1, HOXB4, TIMELESS, TRIB3, PPID, MAX, FOXG1, MEPCE, MTDH, BAG3, TPR, HIVEP1, HESX1, SUDS3, BPTF, TFAP2A, DR1, CREBBP, ZNF263, UBE2I, WFS1, BCL11A, CAV1, NFKB1, CNOT7, CNOT1, PKIA, SP3, CDK2, NFE2L3, ZNF136, EZH2, CIITA, BTG2, TCF25, SUV39H1, OTUD7B, LDB2, FLCN, NIPBL, SIN3A, C1QBP, LRRFIP1, HIF1AN, CIC, JARID2, DACT1, KLF11, HBZ, KLF12, PEG3, RFC1, ARID1A, SIRT2, ZFP90, DUSP22, NCOR2, NCOR1, RBL1, NFX1, MTF2, LCOR, MCPH1, HDAC3, ZNF350, HDAC1, LRP8, RELA, RXRA, DNAJB5, RBBP7, MTA2, E2F7, ZNF189, E2F8, IRX1, PER2, GFI1B, NFIA, NFIB, NFIC, TAF7]
GO:0010839;negative regulation of keratinocyte proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;86.66714155745981;7.212124270218933;0.002900671232564666;0.7197477358342742;[PTPRK]
GO:0006855;drug transmembrane transport;5.0;0.5781283279524737;0.5793051758371571;7.293149336675085;29.084245973375534;5.407625775213448;9.73423538606871E-4;0.5667872454856517;[EBP, TMEM30A, ABCC2, SLC25A19, ABCB4, ARL6IP5, SLC25A10, NTSR1, AQP1]
GO:0050892;intestinal absorption;4.0;0.811012628672052;0.655506314336026;9.176539128749065;23.07461412231494;6.375876246018314;7.722865688694012E-4;0.576062607729944;[VIL1, SCARB1, ABCB4, ACO1, TJP2]
GO:0071475;cellular hyperosmotic salinity response;7.0;0.9326813400603323;0.8172600352873667;9.567899630675686;243.83975882422638;8.390779266560578;0.008161097286311265;0.7800242071602487;[XRCC6, XRCC5, ABCB4]
GO:2000736;regulation of stem cell differentiation;5.0;0.660418147677249;0.6204500856995447;8.475844742553736;27.048145381022124;5.602686357784832;9.052770841523678E-4;0.576762652749597;[ITCH, LBH, HOXB4, ABL1, SOX6, TEAD2]
GO:0034644;cellular response to UV;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;66.19362175939281;5.420364800990877;0.0022154409498949313;0.628117073252615;[CREBBP, CDKN1A, PCNA, RHBDD1, XPC, PTPRK, EIF2S1, CDC25A, AQP1, YY1, DDB1, HIST3H2A, MYC, TP53INP1, PBK, EP300, PPID]
GO:0098911;regulation of ventricular cardiac muscle cell action potential;10.0;0.7866048967936545;0.8085434602577476;9.537552474286395;102.35229487303722;7.138016298065211;0.0034256391983155283;0.7802794972956796;[JUP, CAV1]
GO:0071236;cellular response to antibiotic;4.0;0.6369964171292115;0.5684982085646058;7.703233390639544;41.40086873190647;5.085725745451326;0.0013856498180940687;0.5100842511328143;[BECN1, ACTR2, PCNA, ABCB4, ITPR2, PARK7, RELA, AQP1, SETX, IL6, XRN1, TP53INP1, TIMELESS, PPIF, ABL1, ATP7A, ECT2, EZH2]
GO:0050777;negative regulation of immune response;5.0;0.5193749703860713;0.549928497053956;7.293149336675085;78.83017544275083;4.909539177224887;0.0026383750295169523;0.5413150737011212;[CUEDC2, IL4R, AMBP, ANGPT1, BCR, DUSP22, ABR, FCRLB, CNOT7, CTLA4, A2M, CCR2, HAVCR2]
GO:0035335;peptidyl-tyrosine dephosphorylation;8.0;0.8933024483968273;0.8216512241984136;9.52844079393514;179.24922260518233;5.181953777545879;0.005999310166768488;0.6400053571691908;[PTP4A1, DUSP22, DUSP23, DUSP5, PTPRA, EYA2, DUSP28, PTPN22, PTPRK, SSH3, CDC25A, DUSP14]
GO:2001025;positive regulation of response to drug;5.0;0.6519675769143192;0.6162248003180799;7.963516488903211;42.538124801348104;6.481236761676141;0.0014237127552742665;0.6216917612613706;[RAB3B, GAL, ENDOG, ABCB4, RIPK1]
GO:0050776;regulation of immune response;4.0;0.37937792944451876;0.4396889647222594;5.635843344046521;22.446924158408432;2.846578861728843;7.512783506617425E-4;0.39557417536826767;[CYFIP2, NCKAP1, TFRC, WIPF2, GFI1, CD80, GPATCH3, PARK7, RPS6KA5, NPPA, EP300, IL12A, IFNAR2, LAG3, IL4R, HLA-A, HLA-F, UNC13D, BCR, KARS, CD8B, IL23A, PSPC1, ELMO1, CARD11, ANKRD17, PAXIP1, CFH, SUPT6H, AGER, C2, HSP90B1, C3, NCKIPSD, ABR, CLEC7A, ABL1, SLAMF7, NLRP3, NCKAP1L, RIPK1, A2M, HLA-DQA1, ATG5, EIF2B4, PRNP, CREBBP, XBP1, XRCC6, AMBP, CADM1, BTN2A1, XRCC5, NONO, CAV1, PILRB, PILRA, NFKB1, NFKBIA, IL6, COL1A2, NPLOC4, CNOT7, ARPC2, FES, TREML4, CALM1, HLA-DRB3, CD24, CD200, CUEDC2, CD40, SIGLEC9, C12orf4, ITGB2, ARPC1A, PTPN22, IL27, WASL, FCRLB, AP1G1, SIN3A, C1QBP, CTSH, CTLA4, HRAS, CCR2, HLA-DPA1, HAVCR2, FGA, ACTR2, FCER1G, PVRIG, FCRL3, FGG, BTN3A2, TMEM173, VAV1, VAV2, DUSP22, VAMP8, IRF4, KIT, PIK3C3, LCP2, HLA-DQB1, COLEC12, STOML2, NLRC4, LILRA2, TANK, RELA, UNG, HLA-DMB, CCL5, UBQLN1, LAIR2, CSK, CCL19, EXOSC3, IL12RB1, NPDC1, ANGPT1, P2RX7, ITCH, CD4, POLR3B, POLR3C, TNIP2, HLA-DPB1, MNDA, KRAS, C1QC]
GO:0036146;cellular response to mycotoxin;5.0;0.8933024483968273;0.736892236059334;9.427853557029971;58.05627655683236;8.16763571524637;0.001943091329100457;0.7079342821725234;[ABCB4]
GO:0060333;interferon-gamma-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.514393750639154;0.00101047745553359;0.6329257181104212;[CIITA, IRF4, HLA-DPB1, NCAM1, HLA-A, HLA-DRB3, HLA-F, HLA-DQA1, HLA-DPA1, HLA-DQB1]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[TCERG1, ZNF175, CCNH, GFI1, IKZF1, GPATCH3, IKZF2, ELK1, UBE2L3, MYC, SAP130, ZXDC, DPF2, TRIM24, SOX8, SOX6, IER5, IER2, SAP30BP, CSNK2A1, ZNF282, SND1, EID1, EWSR1, RFX4, HOXB4, TRIB3, ASF1B, ZNF276, ZNF395, ZNF394, PAXIP1, FOXG1, ZNF20, CDCA7, RPAP1, ZNF25, COMMD9, RAD21, HLTF, HIVEP1, HESX1, HOXC4, HIVEP2, ZNF264, ZNF143, XBP1, XRCC6, ZNF263, SETDB1, ZNF260, XRCC5, BCL11A, INTS3, PBX3, EAF2, ZNF35, FLI1, SOX30, STAG1, ZNF30, INTS4, INTS7, ZNF136, EZH2, PHF3, SETD5, BTG2, SETD3, ELL, ZNF250, TCF25, SUV39H1, INTS10, ATF7IP2, HOXC13, BRCA1, WASL, WDR43, NIPBL, CHAF1B, ZMYM2, SCML1, C1QBP, CIC, JARID2, ZNF485, TSC22D4, HELLS, COMMD3, BAZ1A, COMMD1, PPRC1, ZFX, MED29, SIRT2, MED28, NCOR2, NCOR1, NFX1, TFEC, MED20, DEPDC1, VGLL4, ZNF350, HEATR1, ZNF2, ZNF69, RELA, ARNTL, SERTAD3, BCLAF1, SERTAD2, TCEAL3, GPBP1L1, ZNF101, ZNF462, NFYC, ATAD2, GRHL1, GTF2H4, PER2, GFI1B, NFIA, NFIB, NFIC, MARS, ZNF696, MIXL1, ZNF212, ZNF331, CRTC2, NAB1, ARID4A, UBP1, YEATS4, YY1, EP300, ZNF326, ZNF688, ZNF564, GTF2I, TLE4, ZNF441, ZNF680, ZBTB32, SARS, PIAS2, ERN1, ILF3, BRMS1, ZNF93, TBL1XR1, PSPC1, TIMELESS, ADNP, ZNF550, MAX, RLF, SUPT6H, GTF2E2, ZNF549, ZNF548, NLRP3, SUDS3, ZNF544, BPTF, TRAPPC2, TFAP2A, ZBTB17, DR1, NONO, CNOT10, NFKB1, CDK9, CNOT6, IRAK1BP1, TFCP2, COPS5, CNOT7, CNOT1, SP1, SP3, MAFF, BCL3, CNOT3, ZFP64, ZNF658, NFE2L3, ZNF777, CNOT8, TMEM18, MNAT1, ZNF532, ZNF410, NFE2L1, ZSCAN2, PHF19, PHTF2, CIITA, ONECUT2, CHD1, AFF4, LBH, SIN3A, ZNF407, NUP62, ZNF768, ZNF525, ZNF524, ZNF766, LRRFIP1, HIF1AN, KLF11, KLF12, TBP, KLF13, RFC1, BUD31, MKL1, ARNT, SAFB, ARID1A, ZFP90, CREB3, TFDP1, RBL1, ZNF519, TFDP2, ELF4, IRF4, LCOR, ZNF511, ZNF630, ITGB3BP, GTF3C1, SMARCD2, HDAC3, HDAC1, WBP2, CEBPG, TFPT, POLR2B, RBBP5, TP53INP2, FAM120B, TP53INP1, TAF1A, POLR2G, ASCC3, RBBP7, E2F7, ZNF189, E2F8, TBX1, POLR2J3, CHURC1, EYA2, ARID3B, DEK, USF2, POLR3B, POLR3C, TNIP2, POLR3E, TAF7, MNDA, TAF5]
GO:0060856;establishment of blood-brain barrier;4.0;0.8933024483968273;0.6966512241984136;9.34084218004034;32.15320660831846;8.390779266560578;0.001076138889173156;0.6791048419030481;[ABCB4]
GO:0007565;female pregnancy;3.0;1.0;0.6981203125901445;9.628524252492122;32.8060485501291;5.299736813202263;0.0010979889214459554;0.4691490996802742;[CLIC5, OXTR, ABCC2, AMBP, IGFBP5, SPHK2, ITGA2, CAD, LNPEP, COMT, ADIPOR2, CRHR1, BYSL, NPPA, PNOC, KRAS]
GO:0043215;daunorubicin transport;7.0;1.0;0.8509193652572005;9.628524252492122;103.949567617783;9.777073627680469;0.0034790984796300266;0.8509193652572005;[ABCB4]
GO:0002673;regulation of acute inflammatory response;7.0;0.566269677792466;0.6340542041534335;7.857818192461899;34.07149622250282;4.7664383335842135;0.0011403423162113378;0.5946752432987477;[C3, IL6, FCER1G, CFH, C1QBP, NLRP3, PARK7, A2M, DNASE1L3, C1QC, C2]
GO:0006874;cellular calcium ion homeostasis;9.0;0.6324783794010864;0.7124798148808322;8.83001655627435;287.08247441589424;3.7781370657337865;0.009608392061246992;0.5894547304232562;[OXTR, STOML2, CD40, ITPR2, ATP2A2, PKD2, CLN3, GNAT2, TBXA2R, CCL5, ABL1, PDE6B, CCL19, NTSR1, CCR10, GTF2I, CCR2, ATP13A1, WFS1, CAV1, SWAP70, GPR55, P2RX7, CD4, P2RX4, CALM3, CALM1, CD24, CALM2, KCNK3]
GO:0007204;positive regulation of cytosolic calcium ion concentration;11.0;0.6835726970475526;0.7742153008534385;9.097896001429952;290.3013502407617;4.174954806800768;0.00971612493830514;0.645936335304707;[OXTR, CAV1, SWAP70, GPR55, ITPR2, PKD2, P2RX7, CD4, P2RX4, GNAT2, TBXA2R, ABL1, CALM3, CCL19, CALM1, CD24, CALM2, NTSR1, CCR10, CCR2]
GO:0000132;establishment of mitotic spindle orientation;8.0;0.9326813400603323;0.8413406700301662;9.582004236857228;227.84740072539455;6.641579411751319;0.007625847452931234;0.7146506799819907;[NSFL1C, SPRY1, NDC80, PAFAH1B1, MCPH1]
GO:0032735;positive regulation of interleukin-12 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.311337724880743;0.002183412136085803;0.6458824173477649;[CD40, IL23A, CCL19, AGER, RELA]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[UPF1, CXCL6, XBP1, CD40, ABCC2, CCL20, GFI1, CD80, PDCD1LG2, NFKB1, RELA, BCR, IL6, PABPN1, NLRP7, TBXA2R, TNIP2, ABL1, NLRP3, IL12A, HAVCR2]
GO:0070373;negative regulation of ERK1 and ERK2 cascade;11.0;1.0;0.9324289523296623;9.628524252492122;1180.902522994834;5.6339389012889365;0.039523744701365535;0.7205488497465309;[FLCN, ERRFI1, NLRP12, ABL1, CSK, SPRY1]
GO:0006508;proteolysis;5.0;0.5517781253862416;0.5661300745540411;7.338517941704937;47.85814540089318;2.5985281439167696;0.001601769057033345;0.42312986198474045;[CYFIP2, CCNF, PREP, BUB1B, UBE3A, PARK7, UBE2Z, UBE2L3, CNDP2, YY1, PSMD8, NPEPPS, PSMD7, PSMD4, PSMD2, CDC26, MYC, LONP2, PMPCB, SKP2, C18orf25, RNF44, FBXO18, ARRDC1, TRPC4AP, KCTD5, CDC25A, SFRP1, KCTD10, TBL1XR1, PSME2, CHMP4B, ANAPC5, UBR4, COPS7B, COPS7A, ANAPC11, C2, HSP90B1, C3, VCPIP1, CCNB1, RHOT1, RNF213, UBD, NLRP3, USP51, RIPK1, AMZ2, XBP1, UBE2I, TOR1A, SDF2L1, UBE2B, KLHL25, WFS1, EDEM1, RHBDD1, LNPEP, ERLIN2, BTBD6, PGA3, PGA5, NFKB1, NFKBIA, NSFL1C, COPS5, RNF103, NPLOC4, CDC16, FBXL3, TPP1, USP36, USP37, WDR48, PPP1R11, USP32, USP34, KIF14, OTUD7B, BRCA1, ECE2, USP39, SENP6, POLB, TRIM9, CTSO, SCRN1, CASP3, CASP2, CTSH, CTSE, USP46, FGA, SEC13, PDCD6IP, DTX3L, RHBDF2, FGG, RAD23A, SENP2, JOSD1, SIRT2, DDB1, PSMA1, ESPL1, MMP23A, PIK3C3, MAN1B1, USP41, THOP1, MPND, BECN1, STOML2, DERL3, GPS1, RNF38, USP12, DERL2, NEDD8, LRP8, TANK, PARL, PSMB10, PSMA7, RELA, ARNTL, TFPT, CLN3, FZR1, ADAM28, PSMB5, TP53INP2, PERP, PSMB1, ADAM23, UBQLN1, RFFL, SEC11A, SEC11C, RNF20, LRRC29, SYVN1, FBXL15, FBXL16, CAPN13, P2RX7, KBTBD4, ITCH, SPSB1, SPCS2, XPNPEP1, FAP, TNIP2, PSMC1, TRIM32, C1QC, MAD2L1, METAP2]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[HRK, CD40, YWHAB, PARK7, UBE2Z, BBC3, FLCN, AKAP13, RPS6KA2, C1QBP, MYC, CASP3, ARL6IP5, CASP2, CTSH, CTLA4, IL12A, RBM5, PDGFRB, KLF11, DFFA, ENDOG, FBXO18, RPS7, ATPIF1, PLAUR, YWHAZ, SIRT2, VAV1, VAV2, SFRP1, GAL, BRMS1, TFDP1, TFDP2, PTRH2, PPIF, ARHGEF1, ARHGEF5, ITGB3BP, PPID, DIABLO, NLRC4, THBS1, STK3, ABR, BCLAF1, CCL5, UBD, TP53INP1, TP53BP2, NLRP2, ABL1, NLRP3, RIPK1, SUDS3, ZNF622, ECT2, BID, NTSR1, TFAP2A, PRNP, PRELID1, CAV1, EIF2AK3, G0S2, TNFRSF10B, TNFRSF10A, HSPE1, EIF2S1, P2RX7, NLRP12, IL6, FAP, CDK5, MNDA, PDCD1, SERINC3]
GO:0071347;cellular response to interleukin-1;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.446340287394138;0.0027327542132076126;0.6016464081682054;[UPF1, CD40, ABCC2, CCL20, FGG, RORA, TANK, NFKB1, RELA, YY1, SFRP1, NLRP7, CCL5, CCL19]
GO:0030032;lamellipodium assembly;6.0;0.8933024483968273;0.7697715367885581;9.533214072687796;78.21732158183345;6.311337724880743;0.002617863362324714;0.6458824173477649;[CCDC88A, KIT, VAV2]
GO:0035329;hippo signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;6.375876246018314;8.845336528452411E-4;0.6491829203200885;[YWHAB, CASP3, TEAD2, STK3, TJP2]
GO:0031122;cytoplasmic microtubule organization;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;50.45034613020222;5.734022359845919;0.0016885276826141221;0.6163584827319739;[CCDC88A, SPAST, KIF19, KATNAL1, TUBGCP2, CIB1, TUBG1, KPNB1, CLASP1, RAB11A, PAFAH1B1]
GO:0036018;cellular response to erythropoietin;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;8.390779266560578;0.0027327542132076126;0.7522251544931926;[CD40]
